This study is testing a new drug called HRS-7058 for people with a specific type of pancreatic cancer. Pancreatic cancer affects the pancreas, a part of your body that helps digest food. This study is for patients with advanced cancer that has a KRAS G12C mutation, a change in the DNA of the cancer cells. The trial looks at how well the drug works and if it's safe.

• The study involves taking a pill and requires regular doctor visits.
• Participants should expect to be in the study for over 3 months.
• There might be risks, like side effects from the drug.

To join, you need to be 18-75 years old, have already tried other treatments, and be able to swallow pills. You must not have certain health problems like brain issues, heart disease, or be pregnant. If you meet all the entry requirements and agree to follow the study rules, you could be eligible to participate.